Westprop Holdings chief executive Mr Ken Sharpe has rallied the company employees to prioritise speedy execution of their work to meet customer expectations on housing ...
Citi raised the firm’s price target on PTC Therapeutics (PTCT) to $32 from $26 and keeps a Sell rating on the shares. The firm updated the company’s model to reflect the Novartis collaboration, which ...
Ohio lawmakers continue their race to pass bills, focusing this week on adoption, safety, and pension reform. “It’s lame duck,” House Speaker Jason Stephens said with a laugh. “I don’t want to say ...
UBS raised the firm’s price target on PTC Therapeutics (PTCT) to $71 from $47 and keeps a Buy rating on the shares. PTC Therapeutics on Monday announced a global licensing and collaboration agreement ...